Summit Therapeutics NASDAQ:SMMT
UK based company that also trades as LSE:SUMM http://www.summitplc.com/
We are a clinical-stage drug discovery and development company advancing innovative therapies to significantly advance the current standard of treatment for serious unmet medical needs.
Our strategy focuses on two therapy areas: Duchenne Muscular Dystrophy, a fatal genetic muscle wasting disease, and the infectious disease caused by the bacteria C. difficile.
Events and Presentation: http://www.summitplc.com/investors/presentations/
SEC filings: https://www.sec.gov/cgi-bin/browse-edgar?company=Summit+Therapeutics&owner=exclude&action=getcompany All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose. Rules of the board according to IHUB: http://www.investorshub.com/boards/complex_terms.asp